These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 36133310)

  • 1. Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease.
    Maruszczak K; Radzikowski K; Schütz S; Mangge H; Bergsten P; Forslund A; Manell H; Pixner T; Ahlström H; Kullberg J; Mörwald K; Weghuber D
    Front Endocrinol (Lausanne); 2022; 13():1004128. PubMed ID: 36133310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single Point Insulin Sensitivity Estimator in Pediatric Non-Alcoholic Fatty Liver Disease.
    Furthner D; Anderwald CH; Bergsten P; Forslund A; Kullberg J; Ahlström H; Manell H; Ciba I; Mangge H; Maruszczak K; Koren P; Schütz S; Brunner SM; Schneider AM; Weghuber D; Mörwald K
    Front Endocrinol (Lausanne); 2022; 13():830012. PubMed ID: 35185803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
    Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
    World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the ability of insulin resistance and lipid-related indices to predict the presence of NAFLD in obese adolescents.
    Yetim A; Şahin M; Kandemir İ; Bulakçı B; Aksakal MT; Karapınar E; Sever H; Baş F
    Lipids Health Dis; 2024 Jul; 23(1):208. PubMed ID: 38956572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Ferritin Correlates With Liver Fat in Male Adolescents With Obesity.
    Mörwald K; Aigner E; Bergsten P; Brunner SM; Forslund A; Kullberg J; Ahlström H; Manell H; Roomp K; Schütz S; Zsoldos F; Renner W; Furthner D; Maruszczak K; Zandanell S; Weghuber D; Mangge H
    Front Endocrinol (Lausanne); 2020; 11():340. PubMed ID: 32625166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes.
    Wewer Albrechtsen NJ; Junker AE; Christensen M; Hædersdal S; Wibrand F; Lund AM; Galsgaard KD; Holst JJ; Knop FK; Vilsbøll T
    Am J Physiol Gastrointest Liver Physiol; 2018 Jan; 314(1):G91-G96. PubMed ID: 28971838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, clinical & biochemical correlates of non-alcoholic fatty liver disease in overweight adolescents.
    Jain V; Jana M; Upadhyay B; Ahmad N; Jain O; Upadhyay AD; Ramakrishnan L; Vikram NK
    Indian J Med Res; 2018 Sep; 148(3):291-301. PubMed ID: 30425219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
    Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
    Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperglucagonemia in Pediatric Adiposity Associates With Cardiometabolic Risk Factors but Not Hyperglycemia.
    Stinson SE; Jonsson AE; de Retana Alzola IF; Lund MAV; Frithioff-Bøjsøe C; Aas Holm L; Fonvig CE; Pedersen O; Ängquist L; Sørensen TIA; Holst JJ; Christiansen M; Holm JC; Hartmann B; Hansen T
    J Clin Endocrinol Metab; 2022 May; 107(6):1569-1576. PubMed ID: 35213713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperglucagonemia in youth is associated with high plasma free fatty acids, visceral adiposity, and impaired glucose tolerance.
    Manell H; Kristinsson H; Kullberg J; Ubhayasekera SJK; Mörwald K; Staaf J; Cadamuro J; Zsoldos F; Göpel S; Sargsyan E; Ahlström H; Bergquist J; Weghuber D; Forslund A; Bergsten P
    Pediatr Diabetes; 2019 Nov; 20(7):880-891. PubMed ID: 31271247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
    Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
    Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive Value of Adiposity Level, Metabolic Syndrome, and Insulin Resistance for the Risk of Nonalcoholic Fatty Liver Disease Diagnosis in Obese Children.
    Prokopowicz Z; Malecka-Tendera E; Matusik P
    Can J Gastroenterol Hepatol; 2018; 2018():9465784. PubMed ID: 29854716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic inflexibility and insulin resistance in obese adolescents with non-alcoholic fatty liver disease.
    Lee S; Rivera-Vega M; Alsayed HM; Boesch C; Libman I
    Pediatr Diabetes; 2015 May; 16(3):211-8. PubMed ID: 24754380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
    Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
    Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance, but not insulin response, during oral glucose tolerance test (OGTT) is associated to worse histological outcome in obese NAFLD.
    Coccia F; Testa M; Guarisco G; Di Cristofano C; Silecchia G; Leonetti F; Gastaldelli A; Capoccia D
    Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):106-113. PubMed ID: 31677889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triglyceride to high-density lipoprotein cholesterol ratio is an independent predictor of liver fibrosis among pediatrics non-alcoholic fatty liver disease.
    Ting YW; Jalaludin MY; Zaini AA; Mohamed R
    Front Endocrinol (Lausanne); 2022; 13():1071350. PubMed ID: 36589844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of physical activity and fitness with hepatic steatosis, liver enzymes, and insulin resistance in children with overweight/obesity.
    Medrano M; Arenaza L; Migueles JH; Rodríguez-Vigil B; Ruiz JR; Labayen I
    Pediatr Diabetes; 2020 Jun; 21(4):565-574. PubMed ID: 32237015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipid metabolism in non-alcoholic fatty liver disease in patients with different body weights in mid-mountain conditions].
    Toktogulova NA; Sultanalieva RB; Tuhvatshin RR; Kaliev TK
    Ter Arkh; 2023 Jan; 94(12):1361-1366. PubMed ID: 37167179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of neck circumference (NC) as a predictor of non-alcoholic fatty liver disease (NAFLD).
    Hu Y; Chen J; Yang L; Chen P; Li J; Chen L; Chen J; Huang X; Zhang Y; Bu S; Huang Q
    J Clin Transl Endocrinol; 2014 Dec; 1(4):133-139. PubMed ID: 29159094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of non-alcoholic fatty liver disease in obese children.
    Sartorio A; Del Col A; Agosti F; Mazzilli G; Bellentani S; Tiribelli C; Bedogni G
    Eur J Clin Nutr; 2007 Jul; 61(7):877-83. PubMed ID: 17151586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.